Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy
Phytomedicine · 2026-10 · 160 · 158682
DOI: 10.1016/j.phymed.2026.158682 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-10. Verfasst von Fei Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China. Hauptthemen laut MEDLINE: Naphthoquinones, Endoplasmic Reticulum, Urinary Bladder Neoplasms, Autophagy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Southern Medical University.
Abstract (Originalsprache)
BACKGROUND: Bladder cancer (BCa) is a prevalent urinary malignancy with unmet clinical therapeutic needs. Shikonin, a natural anti-tumor compound, exerts anti-BCa activity, yet its direct molecular target and underlying mechanism remain undefined. PURPOSE: This study aimed to identify the direct target of shikonin in BCa and to elucidate the mechanism by which shikonin suppresses tumor progression. METHODS: The anti-BCa effects of shikonin were assessed in vitro and in vivo. Drug affinity responsive target stability (DARTS) combined with 4D quantitative proteomics identified shikonin's direct target, which was validated by molecular docking and cellular thermal shift assay (CETSA). Gain- and loss-of-function experiments and ER-phagy-related assays elucidated the underlying molecular mechanism. RESULTS: Shikonin inhibited BCa cell proliferation, migration, invasion and induced senescence in vitro, and suppressed tumor growth in vivo with no obvious toxicity. Deoxyribonuclease 2 (DNASE2) was identified as shikonin's direct target; shikonin promoted DNASE2 ubiquitination and degradation without altering its mRNA level. DNASE2 was highly expressed in BCa and correlated with poor prognosis, and its knockdown mimicked and enhanced shikonin's anti-BCa effects. Mechanistically, shikonin targeted DNASE2 to downregulate Reticulon 3 (RTN3), thereby inhibiting RTN3-dependent endoplasmic reticulum autophagy (ER-phagy) in BCa. CONCLUSION: This study first identifies DNASE2 as the direct target of shikonin in BCa, and reveals that shikonin exerts anti-BCa activity by promoting DNASE2 ubiquitination/degradation to inhibit the DNASE2/RTN3 axis-mediated ER-phagy. The DNASE2/RTN3 axis is a novel ER-phagy regulatory node in BCa, providing a potential therapeutic target for BCa treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China.
- Department of Cell Biology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, PR China.
- Huiqiao Medical Center, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China. Electronic address: lnhou2010@163.com.
- The School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, PR China. Electronic address: fqin@163.com.
- Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, PR China. Electronic address: twl@smu.edu.cn.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- Southern Medical University
Zitieren
APA
Li, F., Chen, C., Ye, W., Huang, Y., Zhao, X., Li, D., Lai, Y., Lei, Y., Ruan, Z., Ge, L., Li, T., Huang, Y., Deng, F., Hou, L., Fan, Q., & Tan, W. (2026). Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy. Phytomedicine, 160, 158682. https://doi.org/10.1016/j.phymed.2026.158682
Vancouver
Li F, Chen C, Ye W, Huang Y, Zhao X, Li D, et al. Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy. Phytomedicine. 2026;160:158682. doi:10.1016/j.phymed.2026.158682
BibTeX
@article{Li2026,
author = {Li, Fei and Chen, Chen and Ye, Wanteng and Huang, Yuan and Zhao, Xinlei and Li, Dongqing and Lai, Yiqi and Lei, Yuqi and Ruan, Zheng and Ge, Lijin and Li, Tanghua and Huang, Yunjie and Deng, Fan and Hou, Lina and Fan, Qin and Tan, Wanlong},
title = {Shikonin inhibits bladder cancer progression by targeting deoxyribonuclease 2 to suppress reticulon 3-dependent endoplasmic reticulum autophagy},
journal = {Phytomedicine},
year = {2026},
volume = {160},
pages = {158682},
doi = {10.1016/j.phymed.2026.158682}
}
EUVIMED